ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| ICER featured in June 2008 Coverage magazine article |
|
Better Evidence
Reports documenting the resources wasted on medical procedures of questionable effectiveness are prompting industry leaders and policymakers to address these inefficiencies in the nation’s health care system with new urgency. In many cases, information about which treatments are most effective simply does not exist. Often, patients fail to receive what are known to be the best treatments for their conditions because the information is not adequately disseminated or understood. We know little about whether new technologies—often with high price tags—are better than existing and oftentimes lower cost or less invasive technologies. |